InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| G418 (Geneticin) | Single-intraosseous simvastatin injection suppresses cancers via activating C... | 2022 | Biomed Pharmacother. | Yuan W. et al. | DOI: 10.1016/j.biopha.2022.113665 |
| pFUSE2-CLIg-hL2 | In Silico Maturation of a Nanomolar Antibody against the Human CXCR2. | 2022 | Biomolecules | Buratto D. et al. | DOI: 10.3390/biom12091285 |
| pFUSE-CHIg-hG1 | In Silico Maturation of a Nanomolar Antibody against the Human CXCR2. | 2022 | Biomolecules | Buratto D. et al. | DOI: 10.3390/biom12091285 |
| LTA-SA | Myeloid liver kinase B1 contributes to lung inflammation induced by lipoteich... | 2022 | Respir Res. | Pereverzeva L. et al. | DOI: 10.1186/s12931-022-02168-6 |
| Blasticidin | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
| THP1-Dual™ Cells | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
| 2'3'-cGAMP | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
| Zeocin® | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
| THP1-Dual™ KO-STING Cells | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
| THP1-Dual™ KO-TREX1 Cells | Targeting DNA damage response components induces enhanced STING-dependent typ... | 2022 | Oncoimmunology | Lopez-Pelaez M. et al. | DOI: 10.1080/2162402X.2022.2117321 |
| c-di-AMP VacciGrade™ | Gut microbiota modulate radiotherapy-associated antitumor immune responses ag... | 2022 | Gut Microbes | Li Z. et al. | DOI: 10.1080/19490976.2022.2119055 |
| MDP | C/EBPβ Promotes LPS-Induced IL-1β Transcription and Secretion in Alveolar Mac... | 2022 | J Inflamm Res. | Luo Y. et al. | DOI: 10.2147/JIR.S377499 |
| Plasmocin® - Mycoplasma Elimination Reagent | Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induc... | 2022 | Metabolites | Maillard M. et al. | DOI: 10.3390/metabo12090852 |
| Zymosan | Differences in acute phase response to bacterial, fungal and viral antigens i... | 2022 | Sci Rep. | Seltmann A. et al. | DOI: 10.1038/s41598-022-18240-6 |
| Poly(I:C) (HMW) VacciGrade™ | Differences in acute phase response to bacterial, fungal and viral antigens i... | 2022 | Sci Rep. | Seltmann A. et al. | DOI: 10.1038/s41598-022-18240-6 |
| Plasmocin® - Mycoplasma Elimination Reagent | Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induc... | 2022 | Metabolites | Maillard M. et al. | DOI: 10.3390/metabo12090852 |
| LL-37 | Human Cytomegalovirus Induces Vitamin-D Resistance In Vitro by Dysregulating ... | 2022 | Viruses | Stecher C. et al. | DOI: 10.3390/v14092004 |
| Recombinant human IL-1β | Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fi... | 2022 | J Periodontal Res. | Abidi A.H. et al. | DOI: 10.1111/jre.13050 |
| R848 (Resiquimod) | Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is require... | 2022 | Cell Discov. | Yao Y. et al. | DOI: 10.1038/s41421-022-00453-8 |
| Zeocin® | Targeted immunotherapy against distinct cancer-associated fibroblasts overcom... | 2022 | Nat Commun. | Rivas E.I. et al. | DOI: 10.1038/s41467-022-32782-3 |